Education
About Us
Working with TipRanks
Follow Us
Patrick Lamy Insider Profile
4 Followers
Patrick Lamy, SVP, Commercial Strategy at Akero Therapeutics, holds 0.00 shares in Akero Therapeutics (Ticker: AKRO).
Patrick Lamy Akero Therapeutics (AKRO)SVP, Commercial Strategy
Akero Therapeutics (AKRO)
SVP, Commercial Strategy
Not Ranked
Ranked #77,552 out of 105,819 Corporate Insiders
Patrick Lamy has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
Patrick Lamy does not currently own shares as a corporate insider.
A breakdown of Patrick Lamy's holdings
Insider Roles
Patrick Lamy does not currently hold a role as a corporate insider.
Roles that Patrick Lamy holds in companies
Most Profitable Insider Trade
Stock:
Akero Therapeutics
(AKRO)
(AKRO)
Rating:Informative Sell
Date:Dec 12, 2024 - Dec 12, 2025
Return:-88.20%
The most profitable trade made by Patrick Lamy
Patrick Lamy's Trading History
List of latest transactions for each holding click on a transaction to see Patrick Lamy's performance on stock
You May Also Like
Patrick Lamy insider profile FAQ
What is the percentage of profitable transactions made by Patrick Lamy?
The percentage of profitable transactions made by Patrick Lamy is ―.
What is the average return per transaction made by Patrick Lamy?
The average return per transaction made by Patrick Lamy is ―.
What stocks does Patrick Lamy hold?
Patrick Lamy holds: AKRO stocks.
What was Patrick Lamy’s latest transaction?
Patrick Lamy latest transaction was an Uninformative Sell of ―.
What was Patrick Lamy's most profitable transaction?
Patrick Lamy’s most profitable transaction was an Informative Sell of AKRO stock on December 12, 2024. The return on the trade was -88.20%.
What is Patrick Lamy's role in Akero Therapeutics?
Patrick Lamy's role in Akero Therapeutics is SVP, Commercial Strategy.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.